While both the United States and Europe strive to provide excellent cancer care, their systems differ noticeably. The US often emphasizes advanced treatments, sometimes leading to higher costs. In contrast, European systems tend to prioritize proactive care and accessibility, focusing on early diagnosis. This can result in distinct patient experien